The proposed training program seeks to continue to provide multidisciplinary postgraduate research training in academic nephrology to individuals who have previously earned M.D., and/or Ph.D. degrees. Individuals accepted into this program will spend three or more years in essentially fulll-time laboratory research. The program will be enriched with a regularly schedules series of lectures and seminars;participants are also encouraged to enroll in some formal postgraduate copurse work within Harvard Unviersity. It is our belief that the most important component of the proposed program is the intense and virtually undistrubed involvement of trainees in ongoing research prjects within the applicants institution, with close and continuous supervision provided by faculty preceptors many of whom are themselves the recipients and principlal investigators of NIH supported research programs. Emphasis will be placed on intrgation of basic and applied nephrology. The domain of training opportunities in basic research will include the physiological, cellular and molecular biological bases of solute and fluid exchanges across enal epithelia and endothelia, physiology and pharmacology of vasoactive hormiones, the immunological and non-immunological mechanisms operating in renal diseases, and the immunobiology of transplantation These basic approaches will also be appplied, wherever possible, to clinically relevabt areas of investigation, including the creation of animal models of deranged functions of the kidney;extension of immunolfical techniques to ensure more rational recognition of cell surface antigen systems;definition of the fine structure of the major histocompatibility gene complex in man and rodents, and the immunoligcal role of products of its various loci in the process of rejection, tolerance, and enhancement;the nature o and control of effector mechanisms in graft rejection and study of chronic graft-versus-host disease in rodents as a model for immune complex glomerulonephritis. Techniques represented include protein and nucleic acid..

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007527-27
Application #
8116026
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rys-Sikora, Krystyna E
Project Start
1985-07-01
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
27
Fiscal Year
2011
Total Cost
$396,412
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Reeves, Patrick B; Mc Causland, Finnian R (2018) Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension. Clin J Am Soc Nephrol 13:1297-1303
Borges, Thiago J; Murakami, Naoka; Machado, Felipe D et al. (2018) March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity. Nat Commun 9:3482
Garlo, Katherine G; White, William B; Bakris, George L et al. (2018) Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes. Clin J Am Soc Nephrol 13:398-405
Kishi, Seiji; Minato, Masanori; Saijo, Atsuro et al. (2018) IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma. Intern Med 57:1259-1263
Prochaska, Megan; Taylor, Eric; Ferraro, Pietro Manuel et al. (2018) Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones. J Urol 199:1262-1266
Uehara, Mayuko; Solhjou, Zhabiz; Banouni, Naima et al. (2018) Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivity. Sci Rep 8:2461
Gupta, Navin; Susa, Koichiro; Yoda, Yoko et al. (2018) CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells. Curr Protoc Stem Cell Biol 45:e50
Murakami, Naoka; Ding, Yanli; Cohen, David J et al. (2018) Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir). Transpl Infect Dis 20:e12959
Hundemer, Gregory L; Curhan, Gary C; Yozamp, Nicholas et al. (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 6:51-59
Feng, Di; Notbohm, Jacob; Benjamin, Ava et al. (2018) Disease-causing mutation in ?-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch. Proc Natl Acad Sci U S A 115:1517-1522

Showing the most recent 10 out of 132 publications